Prostate cancer is the most common form of internal cancer in Australia with 1 in 4 men at risk of developing prostate cancer in their lifetime. In 2008 more than 20,750 new cases of prostate cancer were diagnosed in Australia and 3,000 men died from the disease. Each year prostate cancer claims more menโs lives in this country than breast cancer does in women. Australian Prostate Cancer (APC) was established to assist with the funding of vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease. APC funds clinical and laboratory based research conducted at the Basil Hetzel Institute for Translational Health Research and The Queen Elizabeth Hospital in South Australia. Australian Prostate Cancer is a Registered Business Name of The Queen Elizabeth Hospital Research Foundation Inc.